Literature DB >> 12511666

Hereditary renal cancers.

Peter L Choyke1, Gladys M Glenn, McClellan M Walther, Berton Zbar, W Marston Linehan.   

Abstract

Hereditary renal cancer syndromes can lead to multiple bilateral kidney tumors that occur at a younger age than do nonhereditary renal cancers. Imaging plays an important role in the diagnosis and management of these syndromes. During the past decade, several new hereditary renal syndromes have been discovered but are not yet widely known. Whereas previously, the list of hereditary renal cancers in adults included von Hippel-Lindau disease and a rare form of chromosomal translocation, the list now includes the following syndromes: tuberous sclerosis, hereditary papillary renal cancer, Birt-Hogg-Dubé syndrome, hereditary leiomyoma renal cell carcinoma, familial renal oncocytoma, hereditary nonpolyposis colon cancer, and medullary carcinoma of the kidney. In addition, a number of newly described but poorly understood syndromes are under investigation. Even at this early stage, it is clear that elucidation of the underlying genetic mutations that cause hereditary renal cancer syndromes will have profound implications for understanding the origins of nonhereditary renal tumors. These studies will likely culminate in a better understanding of the causes of renal cancer, its prevention, and, ultimately, its cure. Copyright RSNA, 2002

Entities:  

Mesh:

Year:  2003        PMID: 12511666     DOI: 10.1148/radiol.2261011296

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  44 in total

Review 1.  Mouse models of inherited cancer syndromes.

Authors:  Sohail Jahid; Steven Lipkin
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

2.  MR Imaging of papillary renal neoplasms: potential application for characterization of small renal masses.

Authors:  Catherine Roy; Benoit Sauer; Véronique Lindner; Hervé Lang; Christian Saussine; Didier Jacqmin
Journal:  Eur Radiol       Date:  2006-06-07       Impact factor: 5.315

Review 3.  Radiologic-pathologic correlations of intratumoral tissue components in the most common solid and cystic renal tumors. Pictorial review.

Authors:  Emilio Quaia; Rossana Bussani; Maria Cova; Roberto Pozzi Mucelli
Journal:  Eur Radiol       Date:  2005-03-08       Impact factor: 5.315

Review 4.  Patient responses to genetic information: studies of patients with hereditary cancer syndromes identify issues for use of genetic testing in nephrology practice.

Authors:  Kimberly A Kaphingst; Colleen M McBride
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

Review 5.  Genetic predisposition to kidney cancer.

Authors:  Laura S Schmidt; W Marston Linehan
Journal:  Semin Oncol       Date:  2016-09-22       Impact factor: 4.929

Review 6.  Imaging for Screening and Surveillance of Patients with Hereditary Forms of Renal Cell Carcinoma.

Authors:  Yuval Freifeld; Lakshmi Ananthakrishnan; Vitaly Margulis
Journal:  Curr Urol Rep       Date:  2018-08-16       Impact factor: 3.092

7.  Uroepithelial and kidney carcinoma in Lynch syndrome.

Authors:  Markku Aarnio; Matti Säily; Matti Juhola; Annette Gylling; Päivi Peltomäki; Heikki J Järvinen; Jukka-Pekka Mecklin
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

Review 8.  Role of percutaneous needle biopsy for renal masses.

Authors:  Elaine M Caoili; Matthew S Davenport
Journal:  Semin Intervent Radiol       Date:  2014-03       Impact factor: 1.513

9.  Tuberous sclerosis with pulmonary lymphangioleiomyomatosis and renal angiomyolipomas. Computed tomographic findings: a case report.

Authors:  Flávia G Vianna; Edson Marchiori; Gláucia Zanetti; Claudia M Mano; Branca Sarcinelli-Luz; Juliana F Carvalho; Carla Assed; Isabella G Santos; Alair A S M D Santos; Alberto D Vianna
Journal:  Cases J       Date:  2009-09-11

Review 10.  Biopsy of renal masses: when and why.

Authors:  V Anik Sahni; Stuart G Silverman
Journal:  Cancer Imaging       Date:  2009-07-06       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.